In this episode, I sat down with Prof Jodhbir S Mehta to talk about something I think a lot of doctors quietly wrestle with: can entrepreneurship and ophthalmology actually co-exist without compromising patient care? We went straight into the public perception problem—when people hear “new tech,” “patents,” or “commercialization,” they sometimes assume doctors are chasing profit. Prof Mehta breaks down how he frames it: innovation is a gamble at the start, and the whole point is to help patients by pushing outcomes forward. He shared a real example from corneal surgery—when they first started doing DSEK back in 2006–2007, techniques were rough and heavily borrowed from what was done elsewhere. Through research and iterative innovation, they designed better ways to do it, and eventually many more patients benefited. The big takeaway for me is that if you want an invention to reach real clinics at scale, academic centers usually can’t manufacture at regulatory standards—so you have to work with industry. And that means learning licensing and patenting, which, honestly, none of us get taught in medical school. The “why” stays the same: patient benefit first, and the entrepreneurial pathway is often how you make that benefit accessible to more people.